Digital tools and biomarkers for cognitive screening: A systematic review - Takeaways - MDSpire

Digital tools and biomarkers for cognitive screening: A systematic review

  • By

  • Seunghui Hong

  • ChanHee Kim

  • Seon Heui Lee

  • June 22, 2026

  • 0 min

Share

  • 1

    The prevalence of dementia is rising globally, with South Korea reporting nearly 890,000 cases among those aged 65 and older in 2021.

  • 2

    Traditional neuropsychological tests like MMSE and MoCA are time-consuming and require trained specialists, limiting their accessibility.

  • 3

    Digital cognitive assessment tools, including mobile applications and AI-assisted systems, offer scalable and precise evaluations for cognitive function.

  • 4

    Digital biomarkers provide continuous, real-life data that can detect subtle cognitive changes, enhancing early screening and monitoring.

  • 5

    Challenges in implementing digital cognitive assessments include score discrepancies, variations in digital literacy, and the need for standardized frameworks.

Original Source(s)

Related Content